One of the nation's largest developers is expanding its San Francisco Bay Area portfolio with the $63 million acquisition of a pair of development sites in the region's most concentrated biotech hub.

One of the nation's largest developers is expanding its San Francisco Bay Area portfolio with the $63 million acquisition of a pair of development sites in the region's most concentrated biotech hub.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
Real Estate